Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Comment by The300on Dec 10, 2010 2:32am
232 Views
Post# 17827771

RE: RE: Our next move up Re: next move up?

RE: RE: Our next move up Re: next move up?

Good evening Whitemoose,

I went back to try and track down the source.

Below are a couple of references to the NSR, with varying timelines. The first one, and more current one, refers to 2011 (no mention of "early 2011") and the latter one refers to "mid-2010" (obviously outdated). I know I read "early 2011" in a report but can't seem to locate it. Nonetheless,based upon my review of the latest presentation (which I reference immediately below), I imagine that "early 2011" is no longer probable..

Bachelor Lake 1% NSR

"Metanor operations at the Bachelor Lake property in Quebec expected to deliver royalties in 2011"
https://halores.com/investors/pdf/Halo-November-2010.pdf

"The 1% net smelter royalty on Batchelor Lake may produce cashflow from mid-2010 onwards. This report gives the investment credentials of the company|"

https://www.proactiveinvestors.com/genera/files/sponsor_files/lom_02_02_10_hlo_report.pdf

With respect to the figure of $50,000 or $60,000 per month,I believe I read that in a report which stated anticipated cash flow would be in the neighbourhood of $50,000/month. I also believe that this number was verified by a Halo representative during one of my conversations with them.

I haven't kept up to date with Metanor, and as such, maybe you can shed some light on their current situation and what type of timeline you believe would be feasible before Halo starts to see cashflow from the NSR.

The 300 (Molon Lave)

<< Previous
Bullboard Posts
Next >>